Skip to content

Analgesic Efficacy of Genicular Nerve Block Versus (IPack Block ) in Patients Undergoing (ACL) Repair

Analgesic Efficacy of Genicular Nerve Block Versus Local Anaesthetic Infiltration Between Popliteal Artery and Capsule of the Knee (IPACK Block ) in Patients Undergoing Anterior Cruciate Ligament (ACL) Repair by Knee Arthroscopy . A Randomized Controlled Prospective Study .

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06404658
Enrollment
120
Registered
2024-05-08
Start date
2024-05-12
Completion date
2024-10-30
Last updated
2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Brief summary

One of the most common injuries to the knee is an anterior cruciate ligament (ACL) sprain or tear due to trauma ACL damage is crippling and often requires repair with an arthroscopic method, which is an outpatient surgery. Nevertheless, patients experience severe postoperative pain on the first day after the ACL reconstruction.Efficient postsurgery pain management is an important part of patient recovery that is also crucial for their satisfaction.

Detailed description

The optimum role of peripheral nerve blocks in ACL reconstruction continue to be debated as a component of multi-modal analgesia . As such ,an ideal block for ACLR would target sensation but not motor function,have minimal complication risk,and be easily reproducible The genicular nerves include branches from the femoral, common peroneal, saphenous, tibial, and obturator nerves which innervate the knee capsule . The superolateral, superomedial, and inferomedial On the other hand, the interspace between the Popliteal Artery and Capsule of the Knee (IPACK) block provides analgesia on the posterior knee joint, and the application of a genicular or IPACK block has been be associated with promising outcomes following the ACLR surgery

Interventions

patients who receive Genicular nerve block with spinal anathesia .

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
15 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

\- Patient age from 18 to 45 years old Patient status ASA I - II Patient body mass index (BMI) \<40 kg/m2

Exclusion criteria

* -Patients were excluded if they refused consent. * Patients who are Not cooperative. * BMI \>40 kg/m2. * Allergy to local anesthetics. * Patients with anticoagulation or bleeding problems. * Previous nerve dysfunction. * Physical status ASA class IV.

Design outcomes

Primary

MeasureTime frameDescription
VAS score48 hourMeasuring pain intensity regarding mean visual analogue score (VAS score ) ranging from 0 (no pain) to 10 (the worst imaginable pain.

Secondary

MeasureTime frameDescription
Ambulatory scoreWithin 48 hourAmbulatory score from ( 0 to 2) (score of 0) is assigned if the activity cannot be performed despite substantial help (score of 1 )is assigned if the activity is performed using personal physical support. (score of 2) is assigned if the activity is performed independently.
Time of first rescue analgesiawithin 24 hourthe time to ask for the first post operative analgesia
Total opioid consumption post operativeWithin 24 hourTotal opioid consumption post operative
Incidence of occurrence of systemic toxicityWithin 24 hour( hypotension ,arrthymias, bradycardia, cardiac arrest, oral numbness and convulsions
The length of hospital stay .within one weekThe length of hospital stay .

Countries

Egypt

Contacts

Primary ContactMariana AbdElsayed Mansour
mrmrsyk4@gmail.com01222960009

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026